CSIMarket Company Name, Ticker, Industry, else..


Labcorp Holdings Inc   (NYSE: LH)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Labcorp Holdings Inc

LH's Fundamental analysis



Looking into Labcorp Holdings Inc growth rates, revenue grew by 45.19 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 1256

Medical Laboratories industry recorded growth of revenues by 6.3 %

Labcorp Holdings Inc realized net income compared to net loss a year ago in IV. Quarter 2024

• More on LH's Growth


Labcorp Holdings Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Labcorp Holdings Inc PEG ratio is at 0.3 Company is currently trading with Price to Cash flow multiple of 20.59 in trailing twelve-month period.
Company
27.11
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 1.55.
Medical Laboratories industry's Price to Sales ratio is at 2.36.


• More on LH's Valuation
 
 Total Debt (Millions $) 5,331
 Dividend TTM ($) 2.88 $
 Dividend Yield TTM (%) 1.19 %
 Revenue/Employee (TTM) $ 216,815
 Net Income/Employee (TTM) $ 12,452
 Receivable Turnover (TTM) 6.37
 Tangible Book Value (Per Share $) -21.41

Labcorp Holdings Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Labcorp Holdings Inc PEG ratio is at 0.3 Company is currently trading with Price to Cash flow multiple of 20.59 in trailing twelve-month period.
Company
27.11
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 1.55.
Medical Laboratories industry's Price to Sales ratio is at 2.36.

Labcorp Holdings Inc Price to Book Ratio is at 2.51 lower than Industry Avg. of 362.87. and higher than S&P 500 Avg. of 0.01

• More on LH's Valuation

•  Market Capitalization (Millions $) 20,214
•  Shares Outstanding (Millions) 84
•  Employees 60,000
•  Revenues (TTM) (Millions $) 13,009
•  Net Income (TTM) (Millions $) 747
•  Cash Flow (TTM) (Millions $) 982
•  Capital Exp. (TTM) (Millions $) -490
•  Total Debt (Millions $) 5,331
•  Dividend TTM ($) 2.88 $
•  Dividend Yield TTM (%) 1.19 %
•  Revenue/Employee (TTM) $ 216,815
•  Net Income/Employee(TTM) $ 12,452
•  Receivable Turnover Ratio (TTM) 6.37
•  Tangible Book Value (Per Share $) -21.41

•  Market Capitalization (Millions $) 20,214
•  Shares Outstanding (Millions) 84
•  Employees 60,000
•  Revenues (TTM) (Millions $) 13,009
•  Net Income (TTM) (Millions $) 747
•  Cash Flow (TTM) (Millions $) 982
•  Capital Exp. (TTM) (Millions $) -490


    LH's Profitability Comparisons
Labcorp Holdings Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in IV. Quarter 2024 to 6.5 % from 7.74 % in III. Quarter.

Labcorp Holdings Inc net profit margin of 4.31 % is currently ranking no. 12 in Medical Laboratories industry, ranking no. 132 in Healthcare sector and number 1521 in S&P 500.


Profitability by Segment
Total 5.17 %



  Ratio
•   Capital Ratio (MRQ) 1.44
•  Total Debt to Equity (MRQ) 0.66
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.75
•  Inventory Turnover Ratio (TTM) 19.83



Labcorp Holdings Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in IV. Quarter 2024 to 6.5 % from 7.74 % in III. Quarter.

Labcorp Holdings Inc net profit margin of 4.31 % is currently ranking no. 12 in Medical Laboratories industry, ranking no. 132 in Healthcare sector and number 1521 in S&P 500.

• More on LH's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com